Cargando…
Kanglaite reverses multidrug resistance of HCC by inducing apoptosis and cell cycle arrest via PI3K/AKT pathway
BACKGROUND: Multidrug resistance (MDR) frequently contributes to the failure of chemotherapeutic treatments in patients diagnosed with hepatocellular carcinoma (HCC). Revealing the molecular mechanism of MDR is indispensable for the development of effective chemotherapeutic drugs. PURPOSE: Due to th...
Autores principales: | Yang, Chendong, Hou, Aihua, Yu, Chunfeng, Dai, Lingling, Wang, Wen, Zhang, Kangle, Shao, Hongmin, Ma, Jinghua, Xu, Wenjuan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5833758/ https://www.ncbi.nlm.nih.gov/pubmed/29520149 http://dx.doi.org/10.2147/OTT.S153814 |
Ejemplares similares
-
Aidi Injection, Compound Kushen Injection, or Kanglaite Injection: Which Is the Best Partner with Systemic Chemotherapy for Patients with HCC? A Network Meta-Analysis
por: Dou, Dou, et al.
Publicado: (2020) -
USP35 promotes HCC development by stabilizing ABHD17C and activating the PI3K/AKT signaling pathway
por: Wang, Linpei, et al.
Publicado: (2023) -
Antitumor effect of Kanglaite® injection in human pancreatic cancer xenografts
por: Liu, Ying, et al.
Publicado: (2014) -
Efficacy of Paclitaxel Combined with Kanglaite Injection in Treatment of Bone Metastases of Lung Cancer
por: CAO, Liming, et al.
Publicado: (2019) -
Effects of Kanglaite Injection on Serum miRNA-21 in Patients with Advanced Lung Cancer
por: Wu, Yue, et al.
Publicado: (2018)